The identification of association between ultrasonographic enthesitis and the ASAS Health Index in patients with axial spondyloarthritis
暂无分享,去创建一个
[1] Coziana Ciurtin,et al. Hidden in plain sight: Is there a crucial role for enthesitis assessment in the treatment and monitoring of axial spondyloarthritis? , 2021, Seminars in arthritis and rheumatism.
[2] E. de Miguel,et al. Enthesis lesions are associated with X‐ray progression in psoriatic arthritis , 2021, International journal of rheumatic diseases.
[3] J. L. Garrido-Castro,et al. ASAS Health Index in patients with spondyloarthritis and its association with disease activity and disease burden including fibromyalgia. , 2021, Clinical and experimental rheumatology.
[4] L. Carmona,et al. Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists , 2020, Rheumatology International.
[5] A. Kamanlı,et al. Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry , 2020, Rheumatology International.
[6] Julie F. Pallant,et al. SPSS Survival Manual , 2020 .
[7] T. Hsieh,et al. Gender difference in ASAS HI among patients with ankylosing spondylitis , 2020, PloS one.
[8] A. Ogdie,et al. Characterization of Patients With Axial Spondyloarthritis by Enthesitis Presence: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry , 2020, ACR open rheumatology.
[9] R. Queiró,et al. Performance of the ASAS Health Index for the Evaluation of Spondyloarthritis in Daily Practice , 2020, The Journal of Rheumatology.
[10] Julie F Pallant,et al. SPSS Survival Manual: A Step by Step Guide to Data Analysis Using IBM SPSS , 2020 .
[11] E. de Miguel,et al. Updating the use of the Madrid Sonographic Enthesis Index (MASEI): a systematic review of the literature. , 2019, Rheumatology.
[12] W. Maksymowych. Biomarkers for Diagnosis of Axial Spondyloarthritis, Disease Activity, Prognosis, and Prediction of Response to Therapy , 2019, Front. Immunol..
[13] D. Baeten,et al. Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis , 2019, RMD Open.
[14] M. Dougados,et al. Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis , 2018, Annals of the rheumatic diseases.
[15] E. Soriano,et al. Enthesitis: from pathophysiology to treatment , 2017, Nature Reviews Rheumatology.
[16] D. Manley,et al. Confounding and collinearity in regression analysis: a cautionary tale and an alternative procedure, illustrated by studies of British voting behaviour , 2017, Quality & Quantity.
[17] D. Loeuille,et al. Relationships between ultrasound enthesitis, disease activity and axial radiographic structural changes in patients with early spondyloarthritis: data from DESIR cohort , 2017, RMD Open.
[18] Fan Wang,et al. Ultrasonographic evaluation of enthesitis in patients with ankylosing spondylitis , 2017, Journal of biomedical research.
[19] D. M. van der Heijde,et al. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis , 2016, Arthritis Research & Therapy.
[20] F. Salaffi,et al. Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis , 2016, Health and Quality of Life Outcomes.
[21] J. Braun,et al. High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort , 2016, Annals of the rheumatic diseases.
[22] A. Iagnocco,et al. Ultrasonographic evaluation of entheses in patients with spondyloarthritis: a systematic literature review. , 2014, Clinical and experimental rheumatology.
[23] D. M. van der Heijde,et al. The ASAS Health Index (ASAS HI) - a new tool to assess the health status of patients with spondyloarthritis. , 2014, Clinical and experimental rheumatology.
[24] D. Evcik,et al. Correlations among enthesitis, clinical, radiographic and quality of life parameters in patients with ankylosing spondylitis , 2014, Modern rheumatology.
[25] George Kollias,et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells , 2013, Annals of the rheumatic diseases.
[26] J. Reveille,et al. Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS , 2013, Annals of the rheumatic diseases.
[27] J. Reveille,et al. Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: Differences in early and late disease , 2013, Arthritis care & research.
[28] T. Mcclanahan,et al. IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells , 2012, Nature Medicine.
[29] M. D’Agostino. Ultrasound imaging in spondyloarthropathies. , 2010, Best practice & research. Clinical rheumatology.
[30] M. Dougados,et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis , 2009, Annals of the rheumatic diseases.
[31] M. Dougados,et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection , 2009, Annals of the rheumatic diseases.
[32] D. M. van der Heijde,et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis , 2008, Annals of the rheumatic diseases.
[33] J. Sampalis,et al. Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index , 2008, Annals of the rheumatic diseases.
[34] E. Naredo,et al. Validity of enthesis ultrasound assessment in spondyloarthropathy , 2008, Annals of the rheumatic diseases.
[35] M. Dougados,et al. Assessment of enthesitis in ankylosing spondylitis , 2003, Annals of the rheumatic diseases.
[36] S P McKenna,et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis , 2003, Annals of the rheumatic diseases.
[37] A. Calin,et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. , 1994, The Journal of rheumatology.
[38] A. Calin,et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. , 1994, The Journal of rheumatology.
[39] A Calin,et al. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. , 1994, The Journal of rheumatology.
[40] A. Cats,et al. Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. , 1985, British journal of rheumatology.
[41] A. Cats,et al. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.